Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
- Conditions
- Melanoma; Renal Cell Carcinoma
- Registration Number
- NCT03728842
- Lead Sponsor
- Indiana University
- Brief Summary
The purpose of this study is to collect blood and clinical data from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression for studies of immune response and other factors that may influence these occurrences.
- Detailed Description
Spontaneous regression in patients with metastatic cancer is an incredibly rare event. It has been described after infection in cancer patients and also rarely in patients with renal cell cancer (usually after resection of the renal primary) and, less commonly, in patients with metastatic melanoma.
Primary Objective To collect peripheral blood from patients with metastatic melanoma and renal cell cancer and spontaneous regression for studies of immune response and other studies.
Secondary Objective To collect clinical data from subjects registered to this study. Clinical data collection will include demographics and cancer characteristics, history and treatment.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 19
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of blood samples collected 1 year samples collected from metastatic melanoma and renal cell cancer patients
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Indiana University Simon Cancer Center
🇺🇸Indianapolis, Indiana, United States
Indiana University Simon Cancer Center🇺🇸Indianapolis, Indiana, United States